Steward Partners Investment Advisory’s Calithera Biosciences, Inc CALA Stock Holding History

Steward Partners Investment Advisory’s Portfolio CALA Stock Details CALA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-20	Closed	-$2K	–	2380
2018 Q3	$2K	Sell	20 -20	-50%	-$1.9K	﹤0.01%	2437
2018 Q2	$4K	Buy	40 +12	+43%	+$1.36K	﹤0.01%	2091
2018 Q1	$3K	Hold	28	–	–	﹤0.01%	1962
2017 Q4	$4K	Buy	28 +18	+180%	+$4.61K	﹤0.01%	1598
2017 Q3	$3K	Buy	+10	New	+$3.15K	﹤0.01%	1445
2017 Q2	–	Sell	-13	Closed	-$2K	–	1724
2017 Q1	$2K	Buy	+13	New	+$2.25K	﹤0.01%	1345

Other funds holding CALA

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Man Group London, United Kingdom $55.1B AUM 24.23% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Steward Partners Investment Advisory's CALA Position: Q4 2018 in Review

Steward Partners Investment Advisory sold out of Calithera Biosciences, Inc (CALA) in Q4 2018, closing a stake of 20 shares — an estimated $2K sold.

Steward Partners Investment Advisory first reported a position in CALA in Q1 2017 and held it in 6 quarters. The position peaked at $4K in Q2 2018. 77 funds tracked by Wall St. Rank hold CALA as of Q4 2018.

Steward Partners Investment Advisory reported no remaining Calithera Biosciences, Inc position as of Q4 2018 after selling out during the quarter.
Steward Partners Investment Advisory sold 20 Calithera Biosciences, Inc shares in Q4 2018, an estimated $2K.
Steward Partners Investment Advisory first reported a position in Calithera Biosciences, Inc in Q1 2017 and held it in 6 quarters.
Steward Partners Investment Advisory's Calithera Biosciences, Inc position peaked at $4K in Q2 2018.
77 funds tracked by Wall St. Rank held Calithera Biosciences, Inc as of Q4 2018.

Based on Steward Partners Investment Advisory's 13F filing for Q4 2018, filed 15 Jan 2019.